Niveles séricos de interleucina-6 en pacientes con diabetes tipo 2 y su correlación con el perfil lipídico

Escalera, Jorge; Pérez, Lorena; Brito, Sara; Lares, Mary; Flores, Luis; Castro, Jorge.
Revista Digital de Postgrado ; 10(2): 309, ago. 2021. tab, graf
Artículo en Español | LILACS, LIVECS | ID: biblio-1418892

Documentos relacionados

  1. Adiponectin in anorexia nervosa and its modifiers: A meta-regression study.
  2. Elevated postprandial triglyceride-rich lipoproteins in patients with diabetes and stable coronary artery disease correlated with early renal damage and systemic inflammation.
  3. The effects of rutin flavonoid supplement on glycemic status, lipid profile, atherogenic index of plasma, brain-derived neurotrophic factor (BDNF), some serum inflammatory, and oxidative stress factors in patients with type 2 diabetes mellitus: A double-blind, placebo-controlled trial.
  4. Anti-inflammatory effect of SGLT-2 inhibitors via uric acid and insulin.
  5. A placebo-controlled proof-of-concept study of alirocumab on postprandial lipids and vascular elasticity in insulin-treated patients with type 2 diabetes mellitus.
  6. Modulation of PPAR-γ, SREBP-1c and inflammatory mediators by luteolin ameliorates ß-cell dysfunction and renal damage in a rat model of type-2 diabetes mellitus.
  7. Two Important Players for Type 2 Diabetes Mellitus: Metrnl and Asprosin.
  8. A six-month low-carbohydrate diet high in fat does not adversely affect endothelial function or markers of low-grade inflammation in patients with type 2 diabetes: an open-label randomized controlled trial.
  9. Elevated angiopoietin-like protein 3 serum levels in diabetic nephropathy patients and its association with renal function and lipid profile.
  10. The Concentrations of Interleukin-6, Insulin, and Glucagon in the Context of Obesity and Type 2 Diabetes and Single Nucleotide Polymorphisms in <i>IL6</i> and <i>INS</i> Genes.